Lunsumio Market Report 2026
Download Free Sample Buy Now
Lunsumio Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Lunsumio Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Lunsumio Market Overview

• The Lunsumio market growth in the historic period has been driven by increasing prevalence of non-hodgkin lymphoma, limited treatment options for relapsed follicular lymphoma

• Market expansion is supported by expansion of personalized cancer treatment approaches, growing adoption of immuno-oncology combinations

• Growth Driver: Increasing Prevalence Of Blood Cancer Drives Growth In The Market

• Market Trend: Growing Focus On Fixed-Duration Bispecific Antibody Therapies Through New Product Launches

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lunsumio Market?

Lunsumio (mosunetuzumab) is a bispecific antibody to treat relapsed or refractory follicular lymphoma. It targets CD20 on B-cells and CD3 on T-cells, aiming to enhance immune system activity against cancer cells. It is approved for patients who have failed prior therapies, offering a novel approach to cancer immunotherapy.

The main formulations of lunsumio are injectable formulation (intravenous) and pre-filled syringes. Injectable formulations in the intravenous (IV) form are drugs prepared for direct administration into the bloodstream. IV formulations of lunsumio provide precise dosing and are used for patients who need immediate therapeutic effects. This type of formulation is preferred in clinical settings, particularly for patients with severe conditions. It is indicated for the treatment of relapsed or refractory follicular lymphoma (FL) and other non-Hodgkin lymphomas. It is distributed through direct sales, wholesalers, distributors, retail pharmacies, and online pharmacies, and is utilized by end users in hospitals, oncology clinics, specialty pharmacies, and research institutions.

Lunsumio Market Global Report 2026 Market Report bar graph

What Is The Lunsumio Market Size and Share 2026?

The growth in the historic period can be attributed to increasing prevalence of non-hodgkin lymphoma, limited treatment options for relapsed follicular lymphoma, rising oncology clinical trial activity, advancement in antibody engineering techniques, regulatory approvals for novel immunotherapies.

What Is The Lunsumio Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of personalized cancer treatment approaches, growing adoption of immuno-oncology combinations, increasing investments in oncology biologics, rising demand for outpatient cancer therapies, continued innovation in bispecific antibody platforms. Major trends in the forecast period include increasing adoption of bispecific antibody therapies, rising focus on t-cell engaging immunotherapies, growing use of precision oncology treatments, expansion of targeted therapies for relapsed lymphomas, enhanced integration of biomarker-based patient selection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Lunsumio Market Segmentation

1) By Formulation: Injectable Formulation (Intravenous), Pre-Filled Syringes

2) By Indication: Treatment Of Relapsed Or Refractory FL, Treatment Of Other Non-Hodgkin Lymphomas

3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients With High-Risk Disease Profiles

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions

What Is The Driver Of The Lunsumio Market?

The increasing prevalence of blood cancer is expected to propel the growth of the lunsumio market going forward. Blood cancer refers to cancers that affect the production and function of blood cells, typically originating in the bone marrow or lymphatic system. The most common types include leukemia, lymphoma, and myeloma. The increasing prevalence of blood cancer can be attributed to factors such as an aging population, genetic predisposition, environmental exposures, weakened immune systems, lifestyle choices, and advancements in diagnostic techniques. Lunsumio (mosunetuzumab) is a bispecific antibody that helps treat blood cancers such as lymphoma by targeting and binding to both cancerous B cells and T cells, enabling the immune system to destroy the cancer cells. It is effective in managing diseases with high blood cancer prevalence, offering a treatment option for patients with relapsed or refractory conditions. For instance, in 2024, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of leukemia cases increased to 62,770, reflecting an increase from 59,610 recorded in 2023. Therefore, the increasing prevalence of blood cancer is driving the growth of the lunsumio industry.

Key Players In The Global Lunsumio Market

Major companies operating in the lunsumio market are Roche Holding AG

Global Lunsumio Market Trends and Insights

A key trend in the Lunsumio market involves advancing innovative approaches, including fixed-duration bispecific antibody therapies, to enhance treatment effectiveness and broaden patient access. Fixed-duration bispecific antibody therapies refer to treatments that use dual-targeting antibodies administered for a set, limited period rather than continuous dosing, enabling effective disease control while reducing long-term treatment burden. For instance, in March 2025, Chugai Pharmaceutical, a Japan-based oncology/biotech company, launched LUNSUMIO for Intravenous Infusion (mosunetuzumab) for relapsed or refractory follicular lymphoma. The therapy is administered as monotherapy in patients who have failed two or more prior treatments, uses a predetermined treatment duration rather than indefinite therapy to reduce long-term treatment burden, and is designed to achieve high complete response rates and potentially durable remission in a difficult-to-treat patient population..

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Lunsumio Market?

In October 2024, Lonza Group AG, a Switzerland-based manufacturing company that supplies pharmaceutical, healthcare, and life science products, acquired the Genentech manufacturing facility from Roche for $1.2 billion. With this acquisition, Lonza Group AG aims to expand its production capacity, enhance its technological capabilities, and strengthen its position as a leading provider of contract development and manufacturing services for the biopharmaceutical industry. Roche Holding AG is a Switzerland-based pharmaceutical company that developed Lunsumio (mosunetuzumab) to treat relapsed or refractory follicular lymphoma.

Regional Insights

North America was the largest region in the lunsumio market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Lunsumio Market?

The lunsumio market consists of sales of lunsumio (mosunetuzumab) 30 mg/30m, and lunsumio (mosunetuzumab -axgb) 1mh/ml. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lunsumio Market Report 2026?

The lunsumio market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lunsumio industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Lunsumio Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Formulation, Indication, Patient Demographics, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Roche Holding AG
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lunsumio Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lunsumio Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lunsumio Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lunsumio Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Industry 4.0 And Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Bispecific Antibody Therapies

4.2.2 Rising Focus On T-Cell Engaging Immunotherapies

4.2.3 Growing Use Of Precision Oncology Treatments

4.2.4 Expansion Of Targeted Therapies For Relapsed Lymphomas

4.2.5 Enhanced Integration Of Biomarker-Based Patient Selection

5. Lunsumio Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Specialty Pharmacies

5.4 Research Institutions

5.5 Cancer Treatment Centers

6. Lunsumio Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lunsumio Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lunsumio PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lunsumio Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lunsumio Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lunsumio Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lunsumio Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lunsumio Market Segmentation

9.1. Global Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Formulation (Intravenous), Pre-Filled Syringes

9.2. Global Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Treatment Of Relapsed Or Refractory FL, Treatment Of Other Non-Hodgkin Lymphomas

9.3. Global Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Patients, Geriatric Patients, Patients With High-Risk Disease Profiles

9.4. Global Lunsumio Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

9.5. Global Lunsumio Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions

10. Lunsumio Market Regional And Country Analysis

10.1. Global Lunsumio Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lunsumio Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lunsumio Market

11.1. Asia-Pacific Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lunsumio Market

12.1. China Lunsumio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lunsumio Market

13.1. India Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lunsumio Market

14.1. Japan Lunsumio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lunsumio Market

15.1. Australia Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Lunsumio Market

16.1. South Korea Lunsumio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Lunsumio Market

17.1. Western Europe Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Lunsumio Market

18.1. UK Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Lunsumio Market

19.1. Germany Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Lunsumio Market

20.1. France Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Lunsumio Market

21.1. Eastern Europe Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Lunsumio Market

22.1. North America Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Lunsumio Market

23.1. USA Lunsumio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Lunsumio Market

24.1. Canada Lunsumio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Lunsumio Market

25.1. South America Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Lunsumio Market

26.1. Middle East Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Lunsumio Market

27.1. Africa Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Lunsumio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Lunsumio Market Regulatory and Investment Landscape

29. Lunsumio Market Competitive Landscape And Company Profiles

29.1. Lunsumio Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Lunsumio Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Lunsumio Market Company Profiles

29.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30. Global Lunsumio Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Lunsumio Market

32. Lunsumio Market High Potential Countries, Segments and Strategies

32.1 Lunsumio Market In 2030 - Countries Offering Most New Opportunities

32.2 Lunsumio Market In 2030 - Segments Offering Most New Opportunities

32.3 Lunsumio Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Lunsumio Market, Overview Of Key Products - Product Examples
  • Table 2: Global Lunsumio Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Lunsumio Market, Supply Chain Analysis
  • Table 4: Global Lunsumio Market, Major Raw Material Providers
  • Table 5: Global Lunsumio Market, Major Resource Providers
  • Table 6: Global Lunsumio Market, Major Manufacturers (Suppliers)
  • Table 7: Global Lunsumio Market, Major Distributors And Channel Partners
  • Table 8: Global Lunsumio Market, Key Technologies & Future Trends
  • Table 9: Global Lunsumio Market, Major Trends
  • Table 10: Global Lunsumio Market, Major End Users
  • Table 11: Global Lunsumio Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Lunsumio Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Lunsumio Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Lunsumio Market - TAM, US$ Billion, 2025
  • Table 15: Global Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Lunsumio Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Lunsumio Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Lunsumio Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Lunsumio Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Western Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: UK, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Germany, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: France, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Eastern Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: North America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: USA, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Canada, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: South America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Middle East, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Africa, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Global Lunsumio Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 74: Global Lunsumio Market - Company Scoring Matrix
  • Table 75: Roche Holding AG Financial Performance
  • Table 76: Global Lunsumio Market, Competitive Benchmarking (In USD Billions)
  • Table 77: Global Lunsumio Market, Competitive Dashboard
  • Table 78: Global Lunsumio Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 79: Global, Lunsumio Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 80: Global, Lunsumio Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 81: Global, Lunsumio Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

    Figure 1: Global Lunsumio Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Lunsumio Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Lunsumio Market, Supply Chain Analysis
  • Figure 4: Global Lunsumio Market, Major Raw Material Providers
  • Figure 5: Global Lunsumio Market, Major Resource Providers
  • Figure 6: Global Lunsumio Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Lunsumio Market, Major Distributors And Channel Partners
  • Figure 8: Global Lunsumio Market, Key Technologies & Future Trends
  • Figure 9: Global Lunsumio Market, Major Trends
  • Figure 10: Global Lunsumio Market, Major End Users
  • Figure 11: Global Lunsumio Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Lunsumio Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Lunsumio Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Lunsumio Market - TAM, US$ Billion, 2025
  • Figure 15: Global Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Lunsumio Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Lunsumio Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Lunsumio Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Lunsumio Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Western Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: UK, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Germany, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: France, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Eastern Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: North America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: USA, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Canada, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: South America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Middle East, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Africa, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Global Lunsumio Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 74: Global Lunsumio Market - Company Scoring Matrix
  • Figure 75: Roche Holding AG Financial Performance
  • Figure 76: Global Lunsumio Market, Competitive Benchmarking (In USD Billions)
  • Figure 77: Global Lunsumio Market, Competitive Dashboard
  • Figure 78: Global Lunsumio Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 79: Global, Lunsumio Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 80: Global, Lunsumio Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 81: Global, Lunsumio Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Oral Biologics & Biosimilar Drugs Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, ...

Monoclonal Antibodies (MAs) Market Report 2026 - Global Outlook – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacologic...

Frequently Asked Questions

The Lunsumio market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Lunsumio market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Lunsumio market Include, Roche Holding AG .

Major trend in this market includes: Growing Focus On Fixed-Duration Bispecific Antibody Therapies Through New Product Launches. For further insights on this market. request a sample here

North America was the largest region in the lunsumio market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lunsumio market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us